0001415889-24-007234.txt : 20240307
0001415889-24-007234.hdr.sgml : 20240307
20240307200222
ACCESSION NUMBER: 0001415889-24-007234
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rose Geoffrey Beran
CENTRAL INDEX KEY: 0001804146
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39562
FILM NUMBER: 24732007
MAIL ADDRESS:
STREET 1: 5124 ROCKWOOD PARKWAY NW
CITY: WASHINGTON
STATE: DC
ZIP: 20016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulmonx Corp
CENTRAL INDEX KEY: 0001127537
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-364-0400
MAIL ADDRESS:
STREET 1: 700 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: PULMONX
DATE OF NAME CHANGE: 20001031
4/A
1
form4a-03082024_010315.xml
X0508
4/A
2024-03-01
2024-03-05
0001127537
Pulmonx Corp
LUNG
0001804146
Rose Geoffrey Beran
C/O PULMONX CORPORATION
700 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
false
true
false
false
CHIEF COMMERCIAL OFFICER
0
Common Stock
2024-03-01
4
A
0
69100
0
A
309052
D
Employee Stock Option (right to buy)
9.30
2024-03-01
4
A
0
34500
0
A
2034-02-28
Common Stock
34500
34500
D
Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.
This amendment is being filed solely to correct the inadvertent typographical errors in the number of shares underlying the Employee Stock Option and Restricted Stock Units and the total securities owned after such transactions as reported in the original Form 4 filed with the SEC on March 5, 2024.
/s/ Lauren Cristina, Attorney-in-Fact
2024-03-07